Programmed cell death protein-1 (PD-1) and cytotoxic T-lymphocyte–associated protein 4 (CTLA-4) are two important immune checkpoints that can impede anti-tumor response when combined with their receptors. The gene discussed is CTLA4; the disease is neoplasm.